NetworkNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Names Senior Advisor to Outline Leadership Strategies
Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator with technology that has demonstrated its ability to enhance the oral delivery of nicotine, recently appointed Gregg Smith, founder of a New York-based culture-tech, venture investment firm, as senior advisor to help define LXRP’s leadership strategies. An article discussing the company reads, “‘I am passionate about creating a smokeless future and recognize that the consumption methods of nicotine and cannabis will change,’ Smith stated in the news release (http://nnw.fm/SY94g). ‘Lexaria’s technology, DehydraTECH(TM), will completely disrupt and improve the consumption and delivery of oral nicotine, CBD and cannabis. Lexaria’s recognition of the recent…







